Showing 6771-6780 of 8826 results for "".
- FDA Approves PMA Supplement for MelaFind from STRATA Scienceshttps://practicaldermatology.com/news/fda-accepts-pma-for-melafind-from-strata-sciences/2458644/The FDA has approved STRATA Skin Sciences, Inc.’s PMA supplement for the MelaFind System. The FDA approved MelaFind’s use of the “classifier score data”, a quantitative result derived by the MelaFind System that can be beneficially used in conjunction with the previously a
- Dark Beer? Green Cabbage? The Scoop on St. Patrick's Day's Hidden Beauty Secretshttps://practicaldermatology.com/news/dark-beer-green-cabbage-the-scoop-on-st-patricks-days-hidden-beauty-secrets/2458647/It’s easy to be green on St. Patrick’s day (March 17th), but many skin care companies are now carrying this torch 365 days a year. And going green isn’t the only St. Paddy’s day tradition that promises beauty benefits. Companies such as
- Revance Therapeutics Appoints Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Developmenthttps://practicaldermatology.com/news/revance-therapeutics-appoints-roman-g-rubio-md-mba-as-senior-vice-president-of-clinical-development/2458649/Revance Therapeutics, Inc. has named Roman G. Rubio, MD, MBA Senior Vice President of Clinical Development. Dr. Rubio will report to Chief Operating Officer Abhay Joshi, and will lead the company’s clinical development team, focusing on further accelerating the advancement of Reva
- New from Olay: Regenerist Micro-Sculpting Cream with SPF 30https://practicaldermatology.com/news/new-from-olay-regenerist-micro-sculpting-cream-with-spf-30/2458657/Olay introduced the newest member of the Regenerist family -- Regenerist Micro-Sculpting Cream with SPF 30 -- at the annual meeting of the American Academy of Dermatology in Washington, DC. Several studies presented here helped lay the groundw
- Vitiligo Working Group Launches Public Awareness Campaignhttps://practicaldermatology.com/news/vitiligo-working-group-launches-public-awareness-campaign/2458665/The Vitiligo Working Group is drawing attention to the many faces of vitiligo with a new public awareness campaign. This initiative rolls out at the 74th Annual Meeting of the American Academy of Dermatology (AAD) in Washington, DC.
- Khloé Kardashian Kicks Off Kybella Campaign in NYChttps://practicaldermatology.com/news/khlo-kardashian-kicks-off-kybella-campaign-in-nyc/2458669/Khloé Kardashian helped Allergan plc kick off their new Live Chin Up campaign. The campaign is designed to help encourage people to not let the things that bother them get in their way. At the event, Kardashian moderated a panel of experts who discussed submental fullnes
- Galderma Launches Three New DTC Campaignshttps://practicaldermatology.com/news/galderma-launches-three-new-dtc-campaigns/2458673/Galderma is rolling out three new direct-to-consumer creative campaigns designed to educate consumers and support Dysport® and Restylane® Silk. The campaigns, which feature unretouched photography, will be supported by significant print,
- Galderma to Begin Two Phase III Restylane Trialshttps://practicaldermatology.com/news/galderma-to-begins-two-phase-iii-restylane-trials/2458679/Galderma is set to initiate a pivotal Phase III trial on Restylane® Lyft for hand augmentation and another that will look to the safety of Restylane® Silk when ad
- CMS: 2015 Hardship Exemption Does Not Impede EHR Incentiveshttps://practicaldermatology.com/news/cms-2015-hardship-exemption-does-not-impede-her-incentives/2458686/The
- FDA Accepts Allergan's sNDA for TEFLARO Use in Childrenhttps://practicaldermatology.com/news/fda-accepts-allergans-snda-for-teflaro-use-in-children/2458700/The U.S. Food and Drug Administration (FDA) has accepted Allergan’s supplemental New Drug Application (sNDA) for IV antibacterial TEFLARO® (ceftaroline fosamil). If approved, this filing will expand the label of TEFLARO beyond adults to include children two months of age a